Diagnostic Methods and Biomarkers in Inflammatory Bowel Disease

Area of Science:

• Gastroenterology
• Immunology
• Medical Diagnostics

Background:

• Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a chronic GI inflammation.
• IBD is thought to result from an exaggerated immune response to gut microbiota in genetically susceptible individuals.
• Delayed diagnosis of IBD can lead to irreversible intestinal damage, dysfunction, and potential surgery.

Purpose of the Study:

• To review the current diagnostic approaches for IBD.
• To highlight the challenges associated with delayed diagnosis.
• To discuss emerging diagnostic biomarkers and technologies for IBD.

Main Methods:

• Review of existing literature on IBD diagnosis.
• Analysis of current diagnostic algorithms including laboratory tests, imaging, and endoscopy.
• Evaluation of various biomarkers (serum, stool, urine) for IBD detection.
• Exploration of novel AI-based diagnostic technologies.

Main Results:

• Current IBD diagnosis relies on a combination of laboratory tests, imaging, and invasive procedures like endoscopy.
• Mild and nonspecific gastrointestinal symptoms frequently contribute to diagnostic delays.
• Various biomarkers and artificial intelligence (AI) tools are under investigation to improve diagnostic accuracy and timeliness.

Conclusions:

• Accurate and timely diagnosis of IBD is critical to prevent severe complications.
• Existing diagnostic methods have limitations, particularly in early or mild cases.
• Emerging AI technologies and novel biomarkers show promise for enhancing future IBD diagnosis and management.